These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31816043)

  • 21. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
    J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bim contributes to the progression of Huntington's disease-associated phenotypes.
    Roberts SL; Evans T; Yang Y; Fu Y; Button RW; Sipthorpe RJ; Cowan K; Valionyte E; Anichtchik O; Li H; Lu B; Luo S
    Hum Mol Genet; 2020 Jan; 29(2):216-227. PubMed ID: 31813995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac dysfunction in the R6/2 mouse model of Huntington's disease.
    Mihm MJ; Amann DM; Schanbacher BL; Altschuld RA; Bauer JA; Hoyt KR
    Neurobiol Dis; 2007 Feb; 25(2):297-308. PubMed ID: 17126554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease.
    Schroeder AM; Wang HB; Park S; Jordan MC; Gao F; Coppola G; Fishbein MC; Roos KP; Ghiani CA; Colwell CS
    PLoS One; 2016; 11(1):e0147269. PubMed ID: 26807590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac mTORC1 Dysregulation Impacts Stress Adaptation and Survival in Huntington's Disease.
    Child DD; Lee JH; Pascua CJ; Chen YH; Mas Monteys A; Davidson BL
    Cell Rep; 2018 Apr; 23(4):1020-1033. PubMed ID: 29694882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
    Ban JJ; Chung JY; Lee M; Im W; Kim M
    Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-type Ca
    Silva FR; Miranda AS; Santos RPM; Olmo IG; Zamponi GW; Dobransky T; Cruz JS; Vieira LB; Ribeiro FM
    Neurobiol Aging; 2017 Jul; 55():1-10. PubMed ID: 28391067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.
    Fatoba O; Kloster E; Reick C; Saft C; Gold R; Epplen JT; Arning L; Ellrichmann G
    Exp Neurol; 2018 Apr; 302():112-128. PubMed ID: 29309751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6/1 mouse model of Huntington's disease.
    Batcha AH; Greferath U; Jobling AI; Vessey KA; Ward MM; Nithianantharajah J; Hannan AJ; Kalloniatis M; Fletcher EL
    Neurobiol Dis; 2012 Mar; 45(3):887-96. PubMed ID: 22198376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease.
    Kiriazis H; Jennings NL; Davern P; Lambert G; Su Y; Pang T; Du X; La Greca L; Head GA; Hannan AJ; Du XJ
    J Physiol; 2012 Nov; 590(22):5845-60. PubMed ID: 22890713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease.
    Valencia A; Reeves PB; Sapp E; Li X; Alexander J; Kegel KB; Chase K; Aronin N; DiFiglia M
    J Neurosci Res; 2010 Jan; 88(1):179-90. PubMed ID: 19642201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
    Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
    J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
    Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
    Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
    Sebastianutto I; Cenci MA; Fieblinger T
    Neurobiol Dis; 2017 Sep; 105():117-131. PubMed ID: 28578004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in the general population.
    Aro AL; Anttonen O; Tikkanen JT; Junttila MJ; Kerola T; Rissanen HA; Reunanen A; Huikuri HV
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):704-10. PubMed ID: 21841194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
    Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
    Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease.
    Yang W; Xie J; Qiang Q; Li L; Lin X; Ren Y; Ren W; Liu Q; Zhou G; Wei W; Saiyin H; Ma L
    Neurosci Bull; 2019 Dec; 35(6):1024-1034. PubMed ID: 31432317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.
    Arteaga-Bracho EE; Gulinello M; Winchester ML; Pichamoorthy N; Petronglo JR; Zambrano AD; Inocencio J; De Jesus CD; Louie JO; Gokhan S; Mehler MF; Molero AE
    Neurobiol Dis; 2016 Dec; 96():144-155. PubMed ID: 27623015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexual behavior and testis morphology in the BACHD rat model.
    Novati A; Yu-Taeger L; Gonzalez Menendez I; Quintanilla Martinez L; Nguyen HP
    PLoS One; 2018; 13(6):e0198338. PubMed ID: 29883458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.